AI drug discovery draws big-pharma deals, new funding and lab ambitions
AI drug discovery is moving into a busier phase: AstraZeneca has agreed a deal with insitro worth up to $1.5 billion, while GSK has expanded its work with Chai Discovery into a...
Started by Watch Desk- Replies
- 0